Cargando…

Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer

PURPOSE: The objective of the current study was to identify the clinicopathological risk factors affecting recurrence after a curative resection for stage I colorectal cancer. METHODS: We retrospectively studied 434 patients who underwent a curative resection for stage I colorectal cancer between Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Keum, Min Ae, Lim, Seok-Byung, Kim, Sun A, Yoon, Yong Sik, Kim, Chan Wook, Yu, Chang Sik, Kim, Jin Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Coloproctology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296942/
https://www.ncbi.nlm.nih.gov/pubmed/22413082
http://dx.doi.org/10.3393/jksc.2012.28.1.49
Descripción
Sumario:PURPOSE: The objective of the current study was to identify the clinicopathological risk factors affecting recurrence after a curative resection for stage I colorectal cancer. METHODS: We retrospectively studied 434 patients who underwent a curative resection for stage I colorectal cancer between January 1999 and December 2004. Postoperative oral chemotherapy was performed in 189 patients (45.3%). The following prognostic factors were correlated with recurrence: age, gender, preoperative carcinoembryonic antigen level, location of tumor, T stage, size of tumor, histologic differentiation, growth pattern, and lymphovascular invasion. The median follow-up duration was 65 months. RESULTS: The overall recurrence rate was 4.6% (20/434). The median time to recurrence was 33 months. Two-thirds of the recurrence occurred more than two years after surgery. Risk factors associated with recurrence were rectal cancer (P = 0.009), T2 stage (P = 0.010), and infiltrative growth pattern (P = 0.020). A Cox proportional hazards regression analysis demonstrated that the infiltrative growth pattern was an independent predictor for recurrence. Tumor cell budding was observed in all pathologic reviews with recurrence. CONCLUSION: Long-term follow-up is necessary for stage I colorectal patients with high risk factors like rectal cancer, T2 stage, and infiltrative growth pattern.